BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 29374691)

  • 21. Whole-Tumor Quantitative Apparent Diffusion Coefficient Histogram and Texture Analysis to Predict Gleason Score Upgrading in Intermediate-Risk 3 + 4 = 7 Prostate Cancer.
    Rozenberg R; Thornhill RE; Flood TA; Hakim SW; Lim C; Schieda N
    AJR Am J Roentgenol; 2016 Apr; 206(4):775-82. PubMed ID: 27003049
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The value of ADC, T2 signal intensity, and a combination of both parameters to assess Gleason score and primary Gleason grades in patients with known prostate cancer.
    Nowak J; Malzahn U; Baur AD; Reichelt U; Franiel T; Hamm B; Durmus T
    Acta Radiol; 2016 Jan; 57(1):107-14. PubMed ID: 25505225
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gleason score at diagnosis predicts the rate of detection of 18F-choline PET/CT performed when biochemical evidence indicates recurrence of prostate cancer: experience with 1,000 patients.
    Cimitan M; Evangelista L; Hodolič M; Mariani G; Baseric T; Bodanza V; Saladini G; Volterrani D; Cervino AR; Gregianin M; Puccini G; Guidoccio F; Fettich J; Borsatti E
    J Nucl Med; 2015 Feb; 56(2):209-15. PubMed ID: 25552670
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stratification of the aggressiveness of prostate cancer using pre-biopsy multiparametric MRI (mpMRI).
    Dwivedi DK; Kumar R; Bora GS; Thulkar S; Sharma S; Gupta SD; Jagannathan NR
    NMR Biomed; 2016 Mar; 29(3):232-8. PubMed ID: 26730884
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantification of angiogenesis by functional computed tomography in a Matrigel model in rats.
    Phongkitkarun S; Kobayashi S; Kan Z; Lee TY; Charnsangavej C
    Acad Radiol; 2004 May; 11(5):573-82. PubMed ID: 15147622
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessment of Prostate Cancer Aggressiveness by Use of the Combination of Quantitative DWI and Dynamic Contrast-Enhanced MRI.
    Hötker AM; Mazaheri Y; Aras Ö; Zheng J; Moskowitz CS; Gondo T; Matsumoto K; Hricak H; Akin O
    AJR Am J Roentgenol; 2016 Apr; 206(4):756-63. PubMed ID: 26900904
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 18F choline PET/CT in the preoperative staging of prostate cancer in patients with intermediate or high risk of extracapsular disease: a prospective study of 130 patients.
    Beheshti M; Imamovic L; Broinger G; Vali R; Waldenberger P; Stoiber F; Nader M; Gruy B; Janetschek G; Langsteger W
    Radiology; 2010 Mar; 254(3):925-33. PubMed ID: 20177103
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Head and neck squamous cell carcinoma: CT perfusion can help noninvasively predict intratumoral microvessel density.
    Ash L; Teknos TN; Gandhi D; Patel S; Mukherji SK
    Radiology; 2009 May; 251(2):422-8. PubMed ID: 19276321
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Investigative clinical study on prostate cancer part IX and X: estradiol and the pituitary-testicular-prostate axis at the time of initial diagnosis and subsequent cluster selection of the patient population after radical prostatectomy.
    Porcaro AB; Ghimenton C; Petrozziello A; Sava T; Migliorini F; Romano M; Caruso B; Cocco C; Antoniolli SZ; Lacola V; Rubilotta E; Monaco C
    Anticancer Res; 2012 Oct; 32(10):4523-32. PubMed ID: 23060581
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of CT perfusion imaging in patients with variously differentiated gastric adenocarcinoma.
    Sun ZQ; Cheng XF; Ge YX; Chen L; Yue JG; Jin LF; Xie ZH; Zhang HD; Xuan YH
    J Xray Sci Technol; 2015; 23(6):737-44. PubMed ID: 26756409
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is further evaluation needed for incidental focal uptake in the prostate in 18-fluoro-2-deoxyglucose positron emission tomography-computed tomography images?
    Hwang I; Chong A; Jung SI; Hwang EC; Kim SO; Kang TW; Kwon DD; Park K; Ryu SB
    Ann Nucl Med; 2013 Feb; 27(2):140-5. PubMed ID: 23076866
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Perfusion CT is a valuable diagnostic method for prostate cancer: a prospective study of 94 patients.
    Luczynska E; Blecharz P; Dyczek S; Stelmach A; Petralia G; Bellomi M; Jereczek-Fossa BA; Jakubowicz J
    Ecancermedicalscience; 2014; 8():476. PubMed ID: 25435904
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of perfusion CT as a follow-up modality after transcatheter arterial chemoembolization: an experimental study in a rabbit model.
    Choi SH; Chung JW; Kim HC; Baek JH; Park CM; Jun S; Kim MU; Lee ES; Cho HR; Jae HJ; Lee W; Park JH
    Invest Radiol; 2010 Jul; 45(7):427-36. PubMed ID: 20440211
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diffusion-weighted imaging predicts upgrading of Gleason score in biopsy-proven low grade prostate cancers.
    Park SY; Oh YT; Jung DC; Cho NH; Choi YD; Rha KH; Hong SJ
    BJU Int; 2017 Jan; 119(1):57-66. PubMed ID: 26823024
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment of bronchial and pulmonary blood supply in non-small cell lung cancer subtypes using computed tomography perfusion.
    Nguyen-Kim TD; Frauenfelder T; Strobel K; Veit-Haibach P; Huellner MW
    Invest Radiol; 2015 Mar; 50(3):179-86. PubMed ID: 25500892
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Revised Gleason grading system is a better predictor of indolent prostate cancer at the time of diagnosis: retrospective clinical-pathological study on matched biopsy and radical prostatectomy specimens.
    Giunchi F; Brunocilla E; Borghesi M; Rizzi S; Ricci MS; Romagnoli D; Martorana G; Schiavina R; Fiorentino M
    Clin Genitourin Cancer; 2014 Oct; 12(5):325-9. PubMed ID: 24583160
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Feasibility Study of Low-dose Prostate CT Perfusion on Third-generation Dual-source CT.
    Zhang G; Sun H; Xue H; Wang Y; Liang J; Xu K; Wang M; Wang M; Jin Z
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2017 Feb; 39(1):101-106. PubMed ID: 28270291
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Apparent diffusion coefficient values are superior to transrectal ultrasound-guided prostate biopsy for the assessment of prostate cancer aggressiveness.
    Li C; Chen M; Wang J; Wang X; Zhang W; Zhang C
    Acta Radiol; 2017 Feb; 58(2):232-239. PubMed ID: 27055916
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of primary prostate cancer using 11C-methionine-PET/CT and 18F-FDG-PET/CT.
    Shiiba M; Ishihara K; Kimura G; Kuwako T; Yoshihara H; Sato H; Kondo Y; Tsuchiya S; Kumita S
    Ann Nucl Med; 2012 Feb; 26(2):138-45. PubMed ID: 22069194
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Presence of high grade tertiary Gleason pattern upgrades the Gleason sum score and is inversely associated with biochemical recurrence-free survival.
    Turker P; Bas E; Bozkurt S; Günlüsoy B; Sezgin A; Postacı H; Turkeri L
    Urol Oncol; 2013 Jan; 31(1):93-8. PubMed ID: 21316989
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.